• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Comprehensive Overview of 6,8-Dichloro-2-methyl-quinoline-4-carboxylic Acid (CAS No. 67059-22-7)

6,8-Dichloro-2-methyl-quinoline-4-carboxylic Acid (CAS No. 67059-22-7) is a specialized quinoline derivative that has garnered significant attention in pharmaceutical and agrochemical research. This compound, characterized by its unique chlorinated quinoline structure, serves as a critical intermediate in the synthesis of various bioactive molecules. Its molecular formula, C₁₁H₇Cl₂NO₂, highlights the presence of two chlorine atoms and a carboxylic acid group, which contribute to its reactivity and versatility in organic transformations.

In recent years, the demand for halogenated quinoline derivatives like 6,8-Dichloro-2-methyl-quinoline-4-carboxylic Acid has surged due to their applications in drug discovery. Researchers are particularly interested in its potential as a building block for antimicrobial agents and anti-inflammatory compounds, aligning with the global focus on combating antibiotic resistance. The compound's methyl-quinoline core also makes it a candidate for developing fluorescent probes, a hot topic in diagnostic imaging and cellular biology.

The synthesis of CAS 67059-22-7 typically involves multi-step reactions, including chlorination and carboxylation of quinoline precursors. Advanced techniques such as microwave-assisted synthesis and catalyzed cross-coupling have been explored to improve yield and purity—addressing common queries about "green chemistry approaches for halogenated quinolines." Analytical methods like HPLC and NMR spectroscopy are essential for quality control, ensuring compliance with industry standards for high-purity intermediates.

From an industrial perspective, 6,8-Dichloro-2-methyl-quinoline-4-carboxylic Acid is often discussed in forums on scalable organic synthesis and cost-effective pharmaceutical intermediates. Its stability under various pH conditions makes it suitable for formulations requiring controlled-release properties, a trending topic in drug delivery systems. Additionally, its role in crop protection chemicals has been investigated, tapping into the growing market for sustainable agrochemicals.

Environmental and safety profiles of CAS 67059-22-7 are frequently searched topics. While not classified as hazardous under standard regulations, proper handling guidelines emphasize personal protective equipment (PPE) and waste disposal protocols. Recent studies have also explored its biodegradability, responding to the increasing demand for eco-friendly chemical solutions in line with ESG (Environmental, Social, and Governance) principles.

In summary, 6,8-Dichloro-2-methyl-quinoline-4-carboxylic Acid exemplifies the intersection of medicinal chemistry and industrial applications. Its adaptability to modern synthetic challenges and relevance to current research trends—such as antibiotic alternatives and green synthesis—ensure its continued prominence in scientific literature and commercial pipelines. Future directions may include computational modeling to predict novel derivatives or bioconjugation techniques for targeted therapies, further expanding its utility.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)